Buy Sun Pharmaceutical on Declines: Angel Broking
Apr 16, 2015
Pick frontline pharma stocks: Sharmila Joshi
Aug 30, 2012
On July 28, 2016 13:59 (IST)
Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.
On July 18, 2016 13:01 (IST)
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
On July 11, 2016 11:18 (IST)
Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.
On June 23, 2016 23:03 (IST)
As per Sebi guidelines, 15 per cent of the buyback offer is reserved for shareholders holding equity shares having market value of not more than Rs 2,00,000 as on the record date.
On June 23, 2016 11:27 (IST)
Shares of pharmaceutical companies such as Lupin, Sun Pharmaceuticals, Dr Reddy's Laboratories and Aurobindo Pharma outperformed today in an otherwise subdued market.
On June 02, 2016 08:48 (IST)
8,243 on Nifty, which is 61.8 per cent retracement of the fall from high of 9,119 hit in March 2015 to low of 6,825 hit in February 2016, is an important level for markets, says Anil Manghnani of Modern Shares and Stock Brokers. The magnitude of rally from lows of 6,825 tells that market was highly oversold, but for a proper rally to continue, the...
On June 02, 2016 00:39 (IST)
Headwinds plaguing Sun Pharmaceutical, India's largest drug maker, will continue for the next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.
On May 31, 2016 16:08 (IST)
Sun Pharmaceutical Industries shares slumped over 5 per cent on Tuesday, following the drugmaker's fourth quarter earnings announcement. Sun Pharmaceutical, India's largest drugmaker, was the top Nifty50 loser today.
On May 31, 2016 15:03 (IST)
Indian shares edged down on Tuesday as investors took profit after five consecutive sessions of gains, but indexes were headed for their third straight monthly rise, outperforming almost all regional markets.
On May 30, 2016 10:59 (IST)
The US Department of Justice (DoJ) on Saturday sought information from Sun Pharma about pricing and marketing of generic drugs that it sells in that country.
On May 27, 2016 16:06 (IST)
Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.
On May 06, 2016 17:34 (IST)
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
On May 03, 2016 15:55 (IST)
Sun Pharmaceuticals Industries' shares fell nearly 4 per cent on Tuesday after its New York Stock Exchange-listed subsidiary Taro Pharmaceutical stopped commercial sales of Keveyis, a drug used in treatment of periodic paralysis.
On April 11, 2016 13:10 (IST)
Sun Pharma stock price rose by nearly 2 per cent on Monday as it received approval from the US health regulator USFDA for its non-steroid drug BromSite used to treat inflammation and prevent pain in patients undergoing cataract surgery.
On March 30, 2016 12:36 (IST)
Shares of Sun Pharma rose by nearly 3 per cent today as the drug major forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
On March 29, 2016 15:08 (IST)
Indian shares were little changed on Tuesday amid caution ahead of the expiry of monthly derivative contracts later this week and a speech from Federal Reserve Chair Janet Yellen later in the day.
On March 16, 2016 13:06 (IST)
Pharma stocks were under strong selling pressure for second consecutive day, weighed down by a weekend order from the government banning over 300 drugs.
On February 02, 2016 16:00 (IST)
UPL, Sun TV Network, MRPL, Jidal Steel, NALCO, Torrent Pharma, JSW Steel and Glenmark were among the losers from the mid-cap space, down 3-4.6 per cent each.